<p>Isolated pDCs from five HIV negative donors were rested overnight, and treated with a panel of stimuli as described in the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0037052#s4" target="_blank">materials and methods</a>. Levels of IFN-α in supernatants were quantified by CBA as part of a panel of other cytokines. (<b>A</b>) Quantified IFN-α (pg/ml) present in culture supernatant of 3–5 donors (N1-N5) at various time points (represented by blue shaded bars) following stimulation by HIV<sub>BAL</sub>, HIV<sub>NL43</sub> or Influenza (<b>B</b>) Mean ± SEM concentrations of IFN-α present in supernatants at various time points following stimulation by HIV<sub>BAL</sub>, (red), HIV<sub>NL43</sub> (orange), Influenza ...
<p>IFNα and IP-10 levels were determined in the plasma of 25 individuals with chronic HIV-1 infectio...
<p>Isolated pDCs from HIV negative donors were treated with Influenza (M.O.I = 0.5), imiquimod (20 µ...
<p>Plasma IFN-I bioactivity measured by the iLite™ bioassay was increased in plasma of HIV-1-infecte...
<p>(A) Gating strategy used to identify CD14 negative BDCA-2 positive CD123 positive pDCs. (B) PBMCs...
<p>Isolated pDCs from HIV negative donors were rested overnight, and treated with a panel of stimuli...
<p>Panel A: PBMCs from males (n = 20) or from females (n = 40) were stimulated with Imiquimod as TLR...
<p>(A) Isolation pDCs. pDCs were enriched by negative selection from PBMCs of healthy donors (n = 4)...
<p><i>(A)</i> mRNA expression of IFNB1 is induced to significantly higher levels in DCs loaded with ...
<p>(A): IFNα and IFNβ mRNA levels in isolated BDCA1<sup>+</sup> cDCs from HIV-negative persons (Neg)...
<p>(A): pDCs were exposed to CpG (3 μg/ml), increasing concentrations of HIV-1 (1 to 20 ng/ml), or i...
<p>(A) PBMCs from SIV-negative SMs and SIV-negative RMs were incubated for 18 hr with 10 µM CL097 or...
<p>(<b>A</b>) Schematic showing duration and frequency of pegylated-IFNα2a administration in partici...
<p>Humanized mice were infected HIV-JRCSF and were treated weekly with 15B or control at 11 weeks po...
Plasmacytoid dendritic cells (pDC) are the major producers of type I interferons (IFNs) in humans an...
<p>Panel A: flow cytometry plot showing expression of IFNα by lymph node-homed pDC from a representa...
<p>IFNα and IP-10 levels were determined in the plasma of 25 individuals with chronic HIV-1 infectio...
<p>Isolated pDCs from HIV negative donors were treated with Influenza (M.O.I = 0.5), imiquimod (20 µ...
<p>Plasma IFN-I bioactivity measured by the iLite™ bioassay was increased in plasma of HIV-1-infecte...
<p>(A) Gating strategy used to identify CD14 negative BDCA-2 positive CD123 positive pDCs. (B) PBMCs...
<p>Isolated pDCs from HIV negative donors were rested overnight, and treated with a panel of stimuli...
<p>Panel A: PBMCs from males (n = 20) or from females (n = 40) were stimulated with Imiquimod as TLR...
<p>(A) Isolation pDCs. pDCs were enriched by negative selection from PBMCs of healthy donors (n = 4)...
<p><i>(A)</i> mRNA expression of IFNB1 is induced to significantly higher levels in DCs loaded with ...
<p>(A): IFNα and IFNβ mRNA levels in isolated BDCA1<sup>+</sup> cDCs from HIV-negative persons (Neg)...
<p>(A): pDCs were exposed to CpG (3 μg/ml), increasing concentrations of HIV-1 (1 to 20 ng/ml), or i...
<p>(A) PBMCs from SIV-negative SMs and SIV-negative RMs were incubated for 18 hr with 10 µM CL097 or...
<p>(<b>A</b>) Schematic showing duration and frequency of pegylated-IFNα2a administration in partici...
<p>Humanized mice were infected HIV-JRCSF and were treated weekly with 15B or control at 11 weeks po...
Plasmacytoid dendritic cells (pDC) are the major producers of type I interferons (IFNs) in humans an...
<p>Panel A: flow cytometry plot showing expression of IFNα by lymph node-homed pDC from a representa...
<p>IFNα and IP-10 levels were determined in the plasma of 25 individuals with chronic HIV-1 infectio...
<p>Isolated pDCs from HIV negative donors were treated with Influenza (M.O.I = 0.5), imiquimod (20 µ...
<p>Plasma IFN-I bioactivity measured by the iLite™ bioassay was increased in plasma of HIV-1-infecte...